Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Participants
NCT07535970Phase 1Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HS-10506, sponsored by Hansoh Pharmaceutical Group. Primary endpoints: Maximum Observed Plasma Concentration at 120 hours, Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration at 120 hours and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
HS-10506
Beyond the preview
Go deeper on NCT07535970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07535970.